Emmanuel Katsanis

Pediatrics

Phone(520) 621-5149
Emailkatsanis@peds.arizona.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Emmanuel Katsanis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Finished

(CRCL) vaccine for Chronic Myelogenous Leukemia
Katsanis, E.
National Institutes of Health
3/1/04 → 4/30/15
Project: Research project
Chaperone rich cell lysates (CRCL)Natural adjuvants and*
Katsanis, E.
National Institutes of Health
7/1/03 → 6/30/06
Project: Research project

3959 Citations
37 h-Index
101 Article
9 Review article
3 Letter
2 Chapter
More
- 1 Comment/debate

Bendamustine Conditioning Skews Murine Host DCs Toward Pre-cDC1s and Reduces GvHD Independently of Batf3
Molina, M. S., Stokes, J., Hoffman, E. A., Eremija, J., Zeng, Y., Simpson, R. J. & Katsanis, E., Jul 16 2020, In: Frontiers in immunology. 11, 1410.
Research output: Contribution to journal › Article › peer-review

Open Access
Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia
Stokes, J., Hoffman, E. A., Molina, M. S., Kummet, N., Simpson, R. J., Zeng, Y. & Katsanis, E., Jan 1 2020, In: OncoImmunology. 9, 1, 1758011.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Exercise as a countermeasure for latent viral reactivation during long duration space flight
Agha, N. H., Mehta, S. K., Rooney, B. V., Laughlin, M. S., Markofski, M. M., Pierson, D. L., Katsanis, E., Crucian, B. E. & Simpson, R. J., Feb 1 2020, In: FASEB Journal. 34, 2, p. 2869-2881 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
6 Scopus citations
Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells
Baker, F. L., Bigley, A. B., Agha, N. H., Pedlar, C. R., O'Connor, D. P., Bond, R. A., Bollard, C. M., Katsanis, E. & Simpson, R. J., Jan 24 2020, In: Frontiers in immunology. 10, 3082.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations
T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies
Katsanis, E., Sapp, L. N., Reid, S. C., Reddivalla, N. & Stea, B., Jun 9 2020, In: Frontiers in Pediatrics. 8, 282.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations

(CRCL) vaccine for Chronic Myelogenous Leukemia

Chaperone rich cell lysates (CRCL)Natural adjuvants and*

Bendamustine Conditioning Skews Murine Host DCs Toward Pre-cDC1s and Reduces GvHD Independently of Batf3

Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia

Exercise as a countermeasure for latent viral reactivation during long duration space flight

Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells

T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies